Skin Irritation Testing for Traditional Chinese Medicine Products

Skin irritation testing is a core non-clinical safety study required for Traditional Chinese Medicine (TCM) products intended for topical, transdermal, or repeated dermal application. Typically performed in healthy white rabbits using the internationally recognized Draize scoring system, these studies determine whether herbal ointments, plasters, liniments, and extracts induce erythema or edema after single or repeated skin exposure. This article provides a technical review of the regulatory basis, sample types, test items, methodology, and practical applications of skin irritation testing for TCM products.

Technical Overview

Skin irritation testing for Traditional Chinese Medicine (TCM) products is an in vivo safety evaluation designed to detect reversible inflammatory damage to the skin, primarily characterized by erythema (redness) and edema (swelling), following dermal contact with a test substance. Because many TCM preparations are applied directly to the skin over extended periods, and because herbal materials contain complex mixtures of active compounds, volatile oils, tannins, and excipients, regulatory authorities require dedicated irritation data before clinical trials or market authorization.

The primary regulatory framework in China includes the National Medical Products Administration (NMPA) and Center for Drug Evaluation (CDE) guideline on non-clinical studies of drug irritation, sensitization, and hemolysis, the current edition of the Chinese Pharmacopoeia, and, for herbal medical devices, the biological evaluation standards aligned with GB/T 16886.10 and ISO 10993-10. Herbal cosmetics are evaluated under the applicable national cosmetic safety and technical standards. Studies intended for regulatory submission are generally conducted in compliance with Good Laboratory Practice (GLP).

The standard model is the healthy adult white rabbit, tested with the final clinical formulation whenever feasible, using a vehicle-controlled design and the Draize visual scoring scale for erythema and edema. Both single-dose (acute) and repeated-dose study designs are available depending on the intended clinical usage pattern of the product.

Testing Samples

External-Use TCM Pharmaceutical Preparations

Finished topical dosage forms represent the largest category of test samples. These include ointments, creams, gels, liniments, tinctures, oils, sprays and aerosols, medicated plasters, cataplasms (gel patches), powders for external wash, and fumigation-washing preparations. Such products frequently contain herbal ingredients known for counterirritant or warming activity, making irritation assessment essential.

TCM Extracts, Fractions, and Active Ingredients

Intermediate materials such as herbal extracts, refined fractions, essential oils, and isolated single compounds intended for incorporation into dermal formulations are tested during preclinical development to characterize the intrinsic irritant potential of the active substances themselves.

Herbal Medical Devices and Wound Dressings

Devices incorporating herbal components, such as antibacterial dressings, adhesive patches with plant extracts, and topical hemostatic materials, are evaluated under biological evaluation standards for medical devices, of which the irritation test is a mandatory component.

Herbal Cosmetics and Consumer Care Products

Skin-care creams, facial masks, essential-oil products, bath additives, foot-soak formulations, and shampoos containing botanical ingredients are tested to demonstrate consumer safety in accordance with cosmetic safety standards.

Veterinary External-Use TCM Preparations

Topical herbal veterinary products, including dermal sprays, washes, and pour-on formulations, are similarly assessed for local tolerance in the target or surrogate species.

Testing Items

The core service scope for TCM skin irritation evaluation typically covers the following study types and endpoints:

• Single-dose (acute) skin irritation test: evaluates local tolerance after one-time dermal exposure.
• Repeated-dose skin irritation test: evaluates cumulative irritation after once-daily application for at least seven and commonly up to fourteen days, or longer if justified by the intended clinical duration.
• Skin sensitization testing (guinea pig maximization test or Buehler test): frequently requested as part of the dermal safety package alongside irritation studies.
• Phototoxicity and photoirritation assessment: relevant for herbal products containing photosensitizing botanical constituents such as furanocoumarins.
• Histopathological examination of treated skin: optional supplementary endpoint to strengthen the interpretation of macroscopic findings.
• Recovery observation period: continued monitoring for up to fourteen days when irritation persists at the end of the dosing phase.

Testing Methods

Animal Selection and Preparation

Healthy adult white rabbits (New Zealand White or Japanese White, commonly 2.0 to 3.0 kg) with intact, undamaged skin are selected. Approximately twenty-four hours before dosing, fur is carefully clipped from the dorsal area on both sides of the spine without abrading the skin. The skin is inspected, and animals with any pre-existing lesions are excluded. Each study includes a vehicle control site, typically on the contralateral side of the same animal, providing a self-controlled comparison.

Single-Dose Test Procedure

The test article, ideally the final clinical formulation, is applied at approximately 0.5 g or 0.5 mL per site to intact skin. The site is covered with gauze and a non-irritant occlusive or semi-occlusive dressing to maintain contact and prevent ingestion. After an exposure period of no less than four hours, the dressing is removed and the site is gently cleaned with warm water to remove residue. Skin reactions are observed and scored at 1, 24, 48, and 72 hours after removal. If effects persist, observation continues until reactions fully reverse or stabilize, generally for up to fourteen days.

Repeated-Dose Test Procedure

The test article is applied to the same dorsal site once daily for at least seven consecutive days, with the exposure duration and regimen matched to the intended clinical use. Before each new application, the site is cleaned and examined, and erythema and edema are scored. This design captures cumulative irritation, delayed onset of reactions, and any deterioration or adaptation of the skin response over time.

Scoring Criteria

Skin reactions are graded according to the Draize scale, and the total irritation score per site is the sum of the erythema and edema scores:

• Erythema and eschar formation: 0 (no erythema), 1 (very slight, barely perceptible), 2 (well-defined), 3 (moderate to severe), 4 (severe with slight eschar formation).
• Edema formation: 0 (no edema), 1 (very slight, barely perceptible), 2 (slight, edges well defined by raising), 3 (moderate, raised approximately 1 mm), 4 (severe, raised more than 1 mm and extending beyond the exposure area).

Evaluation and Classification

The total score per animal site ranges from 0 to 8. The group mean total score is calculated from the observation time points and used to classify irritation intensity as follows:

• 0.00 to 0.49: no irritation.
• 0.50 to 2.99: slight irritation.
• 3.00 to 5.99: moderate irritation.
• 6.00 to 8.00: severe irritation.

The final report integrates macroscopic scores, reversibility of reactions, comparison with the vehicle control, and, where performed, histopathological findings to reach an overall conclusion on local tolerance.

Reporting

A compliant study report includes the test article description and batch information, animal data, detailed methods, individual and mean Draize scores at each time point, photographic documentation of skin sites, classification of irritation intensity, and a GLP quality assurance statement where applicable.

Applications

Skin irritation testing of TCM products supports multiple development and regulatory objectives across the pharmaceutical, device, and consumer product industries:

• New drug registration: providing required non-clinical safety data for Investigational New Drug applications and marketing authorization of topical and transdermal TCM preparations.
• Formulation development and screening: comparing candidate formulations, excipients, and penetration enhancers to select products with an acceptable local tolerance profile.
• Quality and consistency evaluation: verifying that changes in herbal sourcing, extraction processes, or manufacturing sites do not alter the dermal safety profile.
• Biological evaluation of medical devices: fulfilling mandatory irritation endpoints for herbal dressings, patches, and device materials.
• Cosmetic safety assessment: substantiating the safety claims of botanical skincare and personal care products.
• Regulatory support for import and export: supplying recognized local tolerance data for cross-border registration of TCM products.

FAQ

Which animal species are used for TCM skin irritation testing?

Healthy adult white rabbits are the standard and preferred model because their relatively hairless, sensitive skin visibly demonstrates erythema and edema. A minimum of three animals per group is typical, and guinea pigs or mini-pigs may be used for supplementary or alternative dermal safety endpoints.

Does the test need to include abraded skin sites?

Current regulatory guidance emphasizes intact skin as the primary condition, since damaged skin can exaggerate responses and confound interpretation. Abraded-site testing is no longer routinely required but may be added with scientific justification, for example when clinical use on compromised skin is anticipated.

How long does a skin irritation study take?

A single-dose study with in-life observation typically requires approximately one to two weeks, while a repeated-dose study with a seven-to-fourteen-day dosing phase plus recovery observation generally requires three to five weeks, excluding test-system setup and report finalization.

What result indicates that a product is non-irritant?

A group mean total Draize score below 0.5, with no reactions exceeding the vehicle control and full reversibility within the observation period, is classified as no irritation and is generally acceptable for dermal safety purposes.

Can in vitro methods replace the rabbit skin irritation test?

Reconstructed human epidermis models are increasingly used as screening tools during formulation development, and some regulatory frameworks accept them for certain product categories. However, for TCM drug registration submissions, the in vivo rabbit test remains the standard basis for irritation evaluation.